- Home
- IMRN vs LAES Comparison
IMRN vs LAES Comparison
Compare IMRN & LAES Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMRN
- LAES
- Stock Information
- Founded
- IMRN 1994
- LAES 2022
- Country
- IMRN Australia
- LAES Switzerland
- Employees
- IMRN N/A
- LAES N/A
- Industry
- IMRN Biotechnology: Pharmaceutical Preparations
- LAES Semiconductors
- Sector
- IMRN Health Care
- LAES Technology
- Exchange
- IMRN Nasdaq
- LAES Nasdaq
- Market Cap
- IMRN 15.0M
- LAES 12.6M
- IPO Year
- IMRN N/A
- LAES N/A
- Fundamental
- Price
- IMRN $2.25
- LAES $0.42
- Analyst Decision
- IMRN Strong Buy
- LAES Strong Buy
- Analyst Count
- IMRN 1
- LAES 1
- Target Price
- IMRN $5.00
- LAES $1.75
- AVG Volume (30 Days)
- IMRN 7.2K
- LAES 430.4K
- Earning Date
- IMRN 10-22-2024
- LAES 09-25-2024
- Dividend Yield
- IMRN N/A
- LAES N/A
- EPS Growth
- IMRN N/A
- LAES N/A
- EPS
- IMRN N/A
- LAES N/A
- Revenue
- IMRN $3,271,194.00
- LAES $20,135,000.00
- Revenue This Year
- IMRN N/A
- LAES N/A
- Revenue Next Year
- IMRN N/A
- LAES N/A
- P/E Ratio
- IMRN N/A
- LAES N/A
- Revenue Growth
- IMRN 171.67
- LAES N/A
- 52 Week Low
- IMRN $1.48
- LAES $0.29
- 52 Week High
- IMRN $5.96
- LAES $3.95
- Technical
- Relative Strength Index (RSI)
- IMRN 32.37
- LAES 43.44
- Support Level
- IMRN $2.66
- LAES $0.37
- Resistance Level
- IMRN $2.73
- LAES $0.54
- Average True Range (ATR)
- IMRN 0.19
- LAES 0.05
- MACD
- IMRN -0.06
- LAES -0.00
- Stochastic Oscillator
- IMRN 24.04
- LAES 30.95
About IMRN Immuron Limited
Immuron Ltd is a clinical-stage biopharmaceutical company focused on the development and commercialization of a novel class of immunomodulator polyclonal antibodies to treat liver diseases, infectious diseases and other immune-mediated diseases, such as colitis. The company's product, IMM-124E, is a proprietary immunomodulatory agent targeted at GI immune-mediated diseases including fatty liver diseases. The company functions in two segments namely, Research and Development and Hyperimmune products.
About LAES SEALSQ Corp
SEALSQ Corp develops certified secure microcontrollers and implements post-quantum cryptography. The company develops solutions including post-quantum microchips and devices that can be used in a variety of applications, from multi-factor authentication, home automation, and IT network infrastructure to automotive, industrial automation, and control systems. Its vaultIC range offers a complete set of ready-to-use secure elements designed to implement embedded security for any kind of device with fast time-to-market and high flexibility. The company's products include VaultIC155, VaultIV18x, VaultIC292, and VaultIC40x. The company generates a majority of its revenue from North America.